Brainsway Stock Analysis
| BRSYF Stock | USD 2.47 0.00 0.00% |
BrainsWay is undervalued with Real Value of 2.73 and Hype Value of 2.47. The main objective of BrainsWay pink sheet analysis is to determine its intrinsic value, which is an estimate of what BrainsWay is worth, separate from its market price. There are two main types of BrainsWay's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BrainsWay's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BrainsWay's stock to identify patterns and trends that may indicate its future price movements.
The BrainsWay pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BrainsWay is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day. BrainsWay Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BrainsWay's ongoing operational relationships across important fundamental and technical indicators.
BrainsWay |
BrainsWay Pink Sheet Analysis Notes
About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. BrainsWay recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 23rd of May 2011. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.The quote for BrainsWay is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BrainsWay please contact Christopher Jako at 972 2 582 4030 or go to https://www.brainsway.com.BrainsWay Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BrainsWay's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BrainsWay or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| BrainsWay had very high historical volatility over the last 90 days | |
| The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M. | |
| About 20.0% of the company shares are held by company insiders |
BrainsWay Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BrainsWay's market, we take the total number of its shares issued and multiply it by BrainsWay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BrainsWay Profitablity
BrainsWay's profitability indicators refer to fundamental financial ratios that showcase BrainsWay's ability to generate income relative to its revenue or operating costs. If, let's say, BrainsWay is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BrainsWay's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BrainsWay's profitability requires more research than a typical breakdown of BrainsWay's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.37) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29. Technical Drivers
As of the 28th of May, BrainsWay shows the risk adjusted performance of 0.0744, and Mean Deviation of 1.0. BrainsWay technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated eleven technical drivers for BrainsWay, which can be compared to its peers. Please confirm BrainsWay risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if BrainsWay is priced correctly, providing market reflects its regular price of 2.47 per share. Please also double-check BrainsWay information ratio, which is currently at 0.1013 to validate the company can sustain itself at a future point.BrainsWay Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BrainsWay middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BrainsWay. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BrainsWay Predictive Daily Indicators
BrainsWay intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BrainsWay pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BrainsWay Forecast Models
BrainsWay's time-series forecasting models are one of many BrainsWay's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BrainsWay's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BrainsWay Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BrainsWay prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BrainsWay shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BrainsWay. By using and applying BrainsWay Pink Sheet analysis, traders can create a robust methodology for identifying BrainsWay entry and exit points for their positions.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding BrainsWay to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrainsWay. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for BrainsWay Pink Sheet analysis
When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |